Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

On Tuesday, a Cantor analyst wrote that additional data from Amgen’s experimental weight loss injection, MariTide, suggests a ...

Investigators used 3-dimensional quantitative computed tomography to more accurately assess patients’ bone mineral density.

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

Diabetes poses a significant risk to bone health, leading to decreased bone mineral density and increased fracture ...

Research indicates that vitamin D supplementation during pregnancy positively impacts children's bone health and lean mass, ...

The tab contains data on bone density changes in patients who received Amgen’s obesity prospect MariTide in a phase 1 trial.

Cantor analysts said they found the bone mineral density changes when reviewing supplemental data that was published along ...

O rthopedic doctors have a bone to pick with all the people who forget they’re carrying a very important skeleton around ...